Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel cephalosporins reported by Japanese investigators

Jan. 3, 1997

Once-daily oral antibiotic from RPR cleared by FDA

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

New cephalosporins from LG Chemical

Dec. 30, 1996

Lilly describes potential antirhinoviral compounds

Dec. 24, 1996

Forest cleared to market new treatment for cystitis

Dec. 23, 1996

Inex and Bayer end antibiotic research collaboration

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...